SCHEMBL5504133

SCHEMBL5504133

CCOc1ccc(CC=O)cc1CCl

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
TACR2 P21452 1/20 0.43
GABRA1 P14867 3/20 0.42
GABRB2 P47870 3/20 0.42
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
MAPK1 P28482 2/20 0.36
CREBBP Q92793 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509230 0.88 MAPT (0.46) ALDH1A1MAPTPOLBGABRA1GABRB2
SCHEMBL1557719 0.83 ALDH1A1 (0.46) ALDH1A1GABRA1GABRB2
SCHEMBL11864849 0.81 TACR2 (0.51) ALDH1A1MAPTPOLBTACR2CYP2C19
SCHEMBL5518581 0.80 KDM4E (0.39) ALDH1A1MAPTPOLBL3MBTL1LMNA
SCHEMBL8431075 0.80 LMNA (0.49) ALDH1A1MAPTPOLBTACR2L3MBTL1
SCHEMBL9163975 0.79 ALDH1A1 (0.57) ALDH1A1MAPTPOLBTACR2L3MBTL1
SCHEMBL4591571 0.77 LMNA (0.48) ALDH1A1MAPTPOLBTACR2L3MBTL1
SCHEMBL20819545 0.77 LMNA (0.49) ALDH1A1MAPTTACR2CYP2D6CYP2C19
SCHEMBL20615143 0.77 CALM1 (0.58) ALDH1A1MAPTL3MBTL1LMNAKDM4E
SCHEMBL1812946 0.77 KDM1A (0.45) ALDH1A1TACR2GABRA1GABRB2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784182-A1 2-SULFANYL-BENZIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2007-05-16 EP disclosed
WO-2006021418-A1 2-SULFANYL-BENZOIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-02 WO disclosed